Analysts forecast that AFLAC Incorporated (NYSE:AFL) will post sales of $5.56 billion for the current quarter, Zacks reports. Three analysts have provided estimates for AFLAC’s earnings, with the highest sales estimate coming in at $5.66 billion and the lowest estimate coming in at $5.49 billion. AFLAC reported sales of $5.58 billion in the same quarter last year, which would suggest a negative year over year growth rate of 0.4%. The firm is expected to report its next quarterly earnings report on Wednesday, October 23rd.

According to Zacks, analysts expect that AFLAC will report full year sales of $22.08 billion for the current year, with estimates ranging from $21.82 billion to $22.41 billion. For the next financial year, analysts forecast that the firm will post sales of $22.09 billion, with estimates ranging from $21.70 billion to $22.80 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow AFLAC.

AFLAC (NYSE:AFL) last posted its earnings results on Thursday, July 25th. The financial services provider reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.06. AFLAC had a return on equity of 12.94% and a net margin of 14.24%. The firm had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.46 billion. During the same quarter in the prior year, the company earned $1.07 EPS. AFLAC’s revenue was down 1.4% on a year-over-year basis.

A number of equities research analysts recently issued reports on AFL shares. Morgan Stanley upped their target price on AFLAC from $53.00 to $54.00 and gave the company an “equal weight” rating in a research note on Friday, July 26th. Raymond James lowered AFLAC from a “strong-buy” rating to an “outperform” rating and set a $62.00 price target on the stock. in a research note on Monday, July 29th. Evercore ISI lowered AFLAC from an “in-line” rating to an “underperform” rating and set a $56.57 price target on the stock. in a research note on Tuesday, July 16th. ValuEngine lowered AFLAC from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 1st. Finally, Barclays reduced their price target on AFLAC from $53.00 to $49.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. AFLAC currently has an average rating of “Hold” and an average target price of $53.07.

AFL stock traded up $0.14 on Wednesday, reaching $51.91. The company had a trading volume of 155,102 shares, compared to its average volume of 3,496,533. AFLAC has a 1 year low of $41.45 and a 1 year high of $57.18. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.04 and a current ratio of 0.04. The company’s fifty day moving average is $51.53 and its 200 day moving average is $51.73. The company has a market cap of $38.11 billion, a P/E ratio of 12.48, a PEG ratio of 2.86 and a beta of 0.72.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 3rd. Shareholders of record on Wednesday, August 21st were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date was Tuesday, August 20th. AFLAC’s dividend payout ratio is presently 25.96%.

In related news, insider James Todd Daniels sold 5,552 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $52.98, for a total value of $294,144.96. Following the transaction, the insider now directly owns 20,101 shares of the company’s stock, valued at approximately $1,064,950.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Barbara K. Rimer sold 4,728 shares of the stock in a transaction on Friday, July 26th. The stock was sold at an average price of $53.74, for a total value of $254,082.72. Following the completion of the transaction, the director now directly owns 32,448 shares in the company, valued at $1,743,755.52. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,280 shares of company stock worth $757,628. Corporate insiders own 1.30% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of AFL. American Century Companies Inc. raised its position in shares of AFLAC by 86.9% in the 1st quarter. American Century Companies Inc. now owns 6,960,057 shares of the financial services provider’s stock worth $348,003,000 after buying an additional 3,235,386 shares during the period. Nuveen Asset Management LLC raised its position in shares of AFLAC by 2,231.8% in the 2nd quarter. Nuveen Asset Management LLC now owns 3,037,596 shares of the financial services provider’s stock worth $166,490,000 after buying an additional 2,907,329 shares during the period. BlackRock Inc. raised its position in shares of AFLAC by 2.7% in the 1st quarter. BlackRock Inc. now owns 53,029,685 shares of the financial services provider’s stock worth $2,651,483,000 after buying an additional 1,381,807 shares during the period. Acadian Asset Management LLC raised its position in shares of AFLAC by 853.6% in the 1st quarter. Acadian Asset Management LLC now owns 1,475,147 shares of the financial services provider’s stock worth $73,758,000 after buying an additional 1,320,458 shares during the period. Finally, California Public Employees Retirement System raised its position in shares of AFLAC by 17.3% in the 2nd quarter. California Public Employees Retirement System now owns 5,935,191 shares of the financial services provider’s stock worth $325,308,000 after buying an additional 876,489 shares during the period. 64.24% of the stock is currently owned by institutional investors and hedge funds.

AFLAC Company Profile

Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Featured Story: How to Profit and Limit Losses With Stop Orders

Get a free copy of the Zacks research report on AFLAC (AFL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AFLAC (NYSE:AFL)

Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.